Aspira Women’s Health Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aspira Women’s Health Inc. stock issued during period, value, other for the quarter ending 2025-03-31 was $3.34M.
- Aspira Women’s Health Inc. stock issued during period, value, other for the quarter ending 2023-06-30 was $38.00K.
- Aspira Women’s Health Inc. stock issued during period, value, other for the quarter ending 2023-03-31 was $30.00K.
- Aspira Women’s Health Inc. stock issued during period, value, other for the quarter ending 2020-09-30 was $10.65M.
- Aspira Women’s Health Inc. stock issued during period, value, other for fiscal 2024 was $715.00K, a 951.47% increase from fiscal 2023.
- Aspira Women’s Health Inc. stock issued during period, value, other for fiscal 2023 was $68.00K.
- Aspira Women’s Health Inc. stock issued during period, value, other for fiscal 2020 was $10.64M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-03-31 | $3.34M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $715.00K 10-K · filed 2025-03-27 | |
| 2023-12-31 | $68.00K 10-K · filed 2025-03-27 | |
| 2023-06-30 | $38.00K 10-Q · filed 2024-11-19 | |
| 2023-03-31 | $30.00K 10-Q · filed 2024-11-19 | |
| 2020-12-31 | $10.64M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $10.65M 10-Q · filed 2020-11-12 |